Periprosthetic joint infection in patients with multiple arthroplasties.


Journal

The bone & joint journal
ISSN: 2049-4408
Titre abrégé: Bone Joint J
Pays: England
ID NLM: 101599229

Informations de publication

Date de publication:
01 Mar 2023
Historique:
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: epublish

Résumé

Despite numerous studies focusing on periprosthetic joint infections (PJIs), there are no robust data on the risk factors and timing of metachronous infections. Metachronous PJIs are PJIs that can arise in the same or other artificial joints after a period of time, in patients who have previously had PJI. Between January 2010 and December 2018, 661 patients with multiple joint prostheses in situ were treated for PJI at our institution. Of these, 73 patients (11%) developed a metachronous PJI (periprosthetic infection in patients who have previously had PJI in another joint, after a lag period) after a mean time interval of 49.5 months (SD 30.24; 7 to 82.9). To identify patient-related risk factors for a metachronous PJI, the following parameters were analyzed: sex; age; BMI; and pre-existing comorbidity. Metachronous infections were divided into three groups: Group 1, metachronous infections in ipsilateral joints; Group 2, metachronous infections of the contralateral lower limb; and Group 3, metachronous infections of the lower and upper limb. We identified a total of 73 metachronous PJIs: 32 PJIs in Group 1, 38 in Group 2, and one in Group 3. The rate of metachronous infection was 11% (73 out 661 cases) at a mean of four years following first infection. Diabetes mellitus incidence was found significantly more frequently in the metachronous infection group than in non-metachronous infection group. The rate of infection in Group 1 (21.1%) was significantly higher (p = 0.049) compared to Groups 2 (6.2%) and 3 (3%). The time interval of metachronous infection development was shorter in adjacent joint infections. Concordance between the bacterium of the first PJI and that of the metachronous PJI in Group 1 (21/34) was significantly higher than Group 2 (13/38; p = 0.001). The findings of this study suggest that metachronous PJI occurs in more than one in ten patients with an index PJI. Female patients, diabetic patients, and patients with a polymicrobial index PJI are at significantly higher risk for developing a metachronous PJI. Furthermore, metachronous PJIs are significantly more likely to occur in an adjacent joint (e.g. ipsilateral hip and knee) as opposed to a more remote site (i.e. contralateral or upper vs lower limb). Additionally, adjacent joint PJIs occur significantly earlier and are more likely to be caused by the same bacteria as the index PJI.

Identifiants

pubmed: 36854322
doi: 10.1302/0301-620X.105B3.BJJ-2022-0800.R1
pii: BJJ-2022-0800.R1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

294-300

Informations de copyright

© 2023 The British Editorial Society of Bone & Joint Surgery.

Déclaration de conflit d'intérêts

M. Citak reports speaker payments from Waldemar-Link, unrelated to this study. S. Ekhtiari reports fellowship support from the ME Müller Foundation/Hip Society European Fellowship, and research grants from the PSI Foundation, the Michael G. DeGroote Foundation, and the Research Institute of St Joe's Hamilton, all of which are unrelated to this study. T. Gehrke reports speaker payments from Zimmer-Biomet, Waldemar-Link, 3M, and Ceramic, unrelated to this study.

Références

Corona PS , Vicente M , Carrera L , Rodríguez-Pardo D , Corró S . Current actual success rate of the two-stage exchange arthroplasty strategy in chronic hip and knee periprosthetic joint infection . Bone Joint J . 2020 ; 102-B ( 12 ): 1682 – 1688 .
Wildeman P , Rolfson O , Söderquist B , Wretenberg P , Lindgren V . What are the long-term outcomes of mortality, quality of life, and hip function after prosthetic joint infection of the hip? A 10-year follow-up from Sweden . Clin Orthop Relat Res . 2021 ; 479 ( 10 ): 2203 – 2213 .
Yagi H , Kihara S , Mittwede PN , et al. Development of a large animal rabbit model for chronic periprosthetic joint infection . Bone Joint Res . 2021 ; 10 ( 3 ): 156 – 165 .
Murray RP , Bourne MH , Fitzgerald RH . Metachronous infections in patients who have had more than one total joint arthroplasty . J Bone Joint Surg Am . 1991 ; 73-A ( 10 ): 1469 – 1474 .
Gausden EB , Pagnano MW , Perry KI , Suh GA , Berry DJ , Abdel MP . Synchronous periprosthetic joint infections: High mortality, reinfection, and reoperation . J Arthroplasty . 2021 ; 36 ( 10 ): 3556 – 3561 .
Thiesen DM , Mumin-Gündüz S , Gehrke T , et al. Synchronous periprosthetic joint infections . J Bone Joint Surg Am . 2020 ; 102-A ( 4 ): 283 – 291 .
Abblitt WP , Chan EW , Shinar AA . Risk of periprosthetic joint infection in patients with multiple arthroplasties . J Arthroplasty . 2018 ; 33 ( 3 ): 840 – 843 .
Jafari SM , Casper DS , Restrepo C , Zmistowski B , Parvizi J , Sharkey PF . Periprosthetic joint infection: are patients with multiple prosthetic joints at risk? J Arthroplasty . 2012 ; 27 ( 6 ): 877 – 880 .
Luessenhop CP , Higgins LD , Brause BD , Ranawat CS . Multiple prosthetic infections after total joint arthroplasty. Risk factor analysis . J Arthroplasty . 1996 ; 11 ( 7 ): 862 – 868 .
Haverstock JP , Somerville LE , Naudie DD , Howard JL . Multiple periprosthetic joint infections: Evidence for decreasing prevalence . J Arthroplasty . 2016 ; 31 ( 12 ): 2862 – 2866 .
Morgenstern C , Cabric S , Perka C , Trampuz A , Renz N . Synovial fluid multiplex PCR is superior to culture for detection of low-virulent pathogens causing periprosthetic joint infection . Diagn Microbiol Infect Dis . 2018 ; 90 ( 2 ): 115 – 119 .
Bakhtiari IG , Vles G , Busch S-M , et al. Septic failure after one-stage exchange for prosthetic joint infection of the hip: Microbiological implications . J Arthroplasty . 2022 ; 37 ( 2 ): 373 – 378 .
Fillingham YA , Della Valle CJ , Suleiman LI , et al. Definition of successful infection management and guidelines for reporting of outcomes after surgical treatment of periprosthetic joint infection: From the Workgroup of the Musculoskeletal Infection Society (MSIS) . J Bone Joint Surg Am . 2019 ; 101-A ( 14 ): 14 .
Clesham K , Hughes AJ , O’ hEireamhoin S , Fleming C , Murphy CG . Second-site prosthetic joint infection in patients with multiple prosthetic joints . Eur J Orthop Surg Traumatol . 2018 ; 28 ( 7 ): 1369 – 1374 .
Komnos GA , Manrique J , Goswami K , et al. Periprosthetic joint infection in patients who have multiple prostheses in place . J Bone Joint Surg Am . 2020 ; 102-A ( 13 ): 1160 – 1168 .
Lee S-H , Chang C-H , Hu C-C , Chang Y , Hsieh P-H , Lin Y-C . The risk factor and outcome of metachronous periprosthetic joint infections: A retrospective analysis with a minimum ten-year follow-up . J Arthroplasty . 2021 ; 36 ( 11 ): 3734 – 3740 .
Kong L , Cao J , Zhang Y , Ding W , Shen Y . Risk factors for periprosthetic joint infection following primary total hip or knee arthroplasty: a meta-analysis . Int Wound J . 2017 ; 14 ( 3 ): 529 – 536 .
Marculescu CE , Cantey JR . Polymicrobial prosthetic joint infections: risk factors and outcome . Clin Orthop Relat Res . 2008 ; 466 ( 6 ): 1397 – 1404 .
Li Y , Zhang X , Guo X , et al. Effective treatment of single-stage revision using intra-articular antibiotic infusion for polymicrobial periprosthetic joint infection . J Arthroplasty . 2022 ; 37 ( 1 ): 156 – 161 .
Tande AJ , Patel R . Prosthetic joint infection . Clin Microbiol Rev . 2014 ; 27 ( 2 ): 302 – 345 .
Sanders TL , Maradit Kremers H , Schleck CD , Larson DR , Berry DJ . Subsequent total joint arthroplasty after primary total knee or hip arthroplasty: A 40-year population-based study . J Bone Joint Surg Am . 2017 ; 99-A ( 5 ): 396 – 401 .

Auteurs

Rudy Sangaletti (R)

Department of Orthopaedic Surgery, HELIOS ENDO-Klinik Hamburg, Hamburg, Germany.
Sezione di Chirurgia Protesica ad Indirizzo Robotico - Unità di Traumatologia dello Sport, U.O.C Ortopedia e Traumatologia, Fondazione Poliambulanza, Brescia, Italy.

Luigi Zanna (L)

Department of Orthopaedic Surgery, HELIOS ENDO-Klinik Hamburg, Hamburg, Germany.

Mustafa Akkaya (M)

Department of Orthopaedic Surgery, HELIOS ENDO-Klinik Hamburg, Hamburg, Germany.
Department of Orthopaedics and Traumatology, Ankara Yildirim Beyazit University, Ankara, Turkey.

Nemandra Sandiford (N)

Joint Reconstruction Unit, Southland Hospital, Invercargill, New Zealand.

Seper Ekhtiari (S)

Department of Orthopaedic Surgery, HELIOS ENDO-Klinik Hamburg, Hamburg, Germany.

Thorsten Gehrke (T)

Department of Orthopaedic Surgery, HELIOS ENDO-Klinik Hamburg, Hamburg, Germany.

Mustafa Citak (M)

Department of Orthopaedic Surgery, HELIOS ENDO-Klinik Hamburg, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH